Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival
If your provider switches your prescription from one to the other, your injection protocol does not need to change
Recommend appropriate dosage and delivery methods
2 In this study, following 36 weeks of therapy with once weekly SC tirzepatide (10 or 15 mg), participants (n = 670) were randomized to continue tirzepatide or switch to placebo for an additional 52 weeks
PubMed laboratory research record [PMID: 16042906] PubMed record related to this compound for laboratory literature review
